Business · 18/07/2018Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance on Nonprescription Drug Products
Summary
The Food and Drug Administration (FDA) has released a draft guidance for industry on innovative approaches for nonprescription drug products, focusing on two methods to demonstrate safety and effectiveness: enhanced labeling and additional product conditions to facilitate safe consumer use.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →